Results 121 to 130 of about 3,248,511 (314)

One size does not fit all: An in vitro evaluation of the effects of bezafibrate and medroxyprogesterone acetate on human SH‐SY5Y and U‐87 MG cancer cells

open access: yesFEBS Open Bio, EarlyView.
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar   +4 more
wiley   +1 more source

Estimating the healthcare burden of Prurigo Nodularis in England: a CPRD database study

open access: yesJournal of Dermatological Treatment
Purpose: Prurigo nodularis (PN) is a skin disease characterized by intensely itchy skin nodules and is associated with a significant healthcare resource utilization (HCRU).
Donia Bahloul   +10 more
doaj   +1 more source

Re‐Awakening Public Attention to the Silent Pandemic of Cancer Among Older Adults in Low‐ and Middle‐Income Countries

open access: yesAging and Cancer, EarlyView.
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef   +2 more
wiley   +1 more source

Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims Study

open access: yesPatient Preference and Adherence
Oralee J Varnado,1 Michelle Vu,2 Erin K Buysman,2 Gilwan Kim,1 Gayle Allenback,2 Margaret Hoyt,1 Helen Trenz,2 Feng Cao,2 Lars Viktrup1 1Eli Lilly and Company, Indianapolis, IN, USA; 2Optum Life Sciences, HEOR, Eden Prairie, MN, USACorrespondence: Oralee
Varnado OJ   +8 more
doaj  

Estimating the direct costs of oral cancer in Spain: a retrospective hospital data analysis. [PDF]

open access: yesMed Oral Patol Oral Cir Bucal, 2023
Porta-Vázquez M   +5 more
europepmc   +1 more source

Dundee Discussion Papers in Economics 137:Employment protection and globalisation in dynamic oligopoly [PDF]

open access: yes, 2003
We construct a model in which oligopolistic firms decide where to locate. Firms choose to locate either in a country where employment protection implies costly output adjustments or in one without adjustment costs.
Dewit, Gerda   +2 more
core   +1 more source

Aging Is a Key Driver for Adult Acute Myeloid Leukemia

open access: yesAging and Cancer, EarlyView.
Acute myeloid leukemia (AML) is a classical age‐related hematologic malignancy, and a key driver of AML is aging, which profoundly regulates intrinsic factors such as genomic instability, epigenetic reprogramming, and metabolic dysregulation, and alters bone marrow microenvironment.
Rong Yin, Haojian Zhang
wiley   +1 more source

Evaluation of expenses for treatment of patients with different forms of psoriasis in the conditions of round-the-clock hospital [PDF]

open access: yesСаратовский научно-медицинский журнал, 2017
 Objective: to evaluate the structure and volume of expenditures on treatment of patients with different clinical forms of psoriasis using the method of analysis of "cost of illness". Material and Methods. The study was conducted on the basis of the
Nelyubova O.I., Sazanova G.Yu., Utz S/R.
doaj  

Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer

open access: yesAging and Cancer, EarlyView.
Women threated with adjuvant chemotherapy for early breast cancer have sustained long‐term increase in p16INK4a,, a robust marker of cell senescence, suggesting a chemotherapy‐associated age acceleration. p16INK4a as well as other biomarkers may identify patients at greatest risk for senescence‐related diseases of aging.
Hyman B. Muss   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy